Denali 10-Year review

It depends — and the main variable is how much the carrier rating matters to you. If carrier financial strength is at the top of your criteria, a B-rated insurer holding your money for 10 years is a hard sell. If you've weighed that risk and decided the product mechanics justify it, Denali 10-Year has real merit: a broad crediting menu, zero floor on all indexed strategies, a competitive fixed rate, and illness waivers built in at no cost. It is not a bad product. It requires a buyer who understands what they're accepting.

The practical reason to buy this over a higher-rated competitor is often access to a strategy that isn't available elsewhere — particularly the participation-rate options on proprietary indices like Barclays Atlas 5, Bloomberg Versa 10, and Nasdaq Generations 5, which can carry participation rates up to 220% in some configurations. Someone who has already satisfied their carrier-quality concerns and is optimizing for crediting potential might find the menu here more attractive than what a larger carrier's 10-year FIA offers. The $10,000 minimum is also lower than many peers, which opens the door to buyers with smaller initial allocations.

I think Denali 10-Year is best for a buyer in their 50s or early 60s with a genuine 10-year horizon, a qualified account (the RMD-friendly provisions matter here), and a clear-eyed view of SILAC's financial strength profile. It is less suitable for someone who might need more than RMDs in the first year, anyone who prioritizes A-rated or better carriers, or someone who wants the simplicity of a straightforward capped-index structure without the added complexity of recapture provisions.

You are buying an insurance contract that credits interest based on the performance of selected market indices while protecting your principal from negative index returns. You do not participate directly in the market — instead, your return is shaped by caps, participation rates, or spreads depending on which strategy you choose. The 0% annual floor means you cannot lose credited gains due to index performance, but you can still lose money if you exit early through surrender charges, the Market Value Adjustment, or the Interest Bonus Recovery recapture. Those exit costs are the real risk in this contract, not the indices themselves.

Denali 10-Year offers 12 indexed strategies plus a fixed account. Indexed strategies span four methods — annual point-to-point, monthly point-to-point, monthly averaging, and point-to-point with participation rates — across six indices: S&P 500, Barclays Atlas 5, Bloomberg Versa 10, Nasdaq Generations 5, S&P 500 Duo Swift, and S&P 500 RavenPack Artificial Intelligence.

The S&P 500 annual point-to-point strategy has a 9.50% cap with 100% participation, which is competitive for a 10-year FIA. There is also an uncapped 60% participation version on the S&P 500. The proprietary indices — Barclays Atlas 5, Bloomberg Versa 10, and Nasdaq Generations 5 — use spread-based crediting, where SILAC subtracts a spread (roughly 4.25%–4.50%) from the index return before crediting interest. On those strategies, the index needs to meaningfully outperform the spread before any interest is credited. These indices are designed with volatility controls, which generally means smoother but lower returns than a raw S&P 500 strategy.

The monthly point-to-point strategy on the S&P 500 has a 3.25% monthly cap but no monthly downside cap, which means a single bad month can wipe gains from positive months — a mechanic worth understanding before allocating there. The fixed account option (4.75% as of the rate sheet date) provides a straightforward alternative for buyers who prefer a declared rate.

The most meaningful secondary feature is the trio of built-in illness waivers: a Nursing Home Benefit, a Terminal Illness Benefit, and a Home Health Care Benefit — all included at no additional cost. For a 10-year product, this matters more than it would for a shorter duration. If a buyer develops a qualifying condition during the surrender period, these waivers allow access to contract value without the standard surrender charge, MVA, or recapture fees applying. That is real protection for a real risk at a 10-year time horizon, and the fact that it comes without a rider fee is a genuine benefit.

Note: the Home Health Care and Nursing Home benefits are not available in South Dakota.

This contract is built for patient, long-term capital. Year 1 allows only RMDs as free withdrawals — there is no standard 5% or 10% free-withdrawal option in the first contract year. Starting in Year 2, up to 5% of account value can be withdrawn annually (one withdrawal per year) without triggering charges. RMDs are always treated as free withdrawals and can exceed 5%.

The optional Elevation rider (0.50% annual spread) or Elevation Plus rider (1.00% annual spread) expands free access to 10% annually with up to 30% cumulative carryover — but those riders come with a cost and cannot be removed after issue.

The surrender schedule starts at 12% for the first two years, which is heavier than the 10% opening seen on most 10-year peers. On top of that, SILAC applies an **Interest Bonus Recovery** recapture on surrenderable withdrawals. This recapture begins at 100% in Year 1 and steps down to 50% in Year 10 — meaning SILAC can recover a portion of any interest bonus previously credited when you take an otherwise-penalized withdrawal. Combine this with the MVA — which can move either direction depending on interest rate conditions — and an early exit is meaningfully more costly here than on many competitor contracts.

The base contract carries no annual fee. The optional Elevation rider costs 0.50% as an annual spread on account value; Elevation Plus costs 1.00%. These riders cannot be terminated after issue, so adding one is a permanent decision. That 1.00% annual drag on Elevation Plus is meaningful over 10 years and should be weighed against the enhanced liquidity it provides.

The spread-based proprietary index strategies have embedded spreads of roughly 4.25%–4.50%, which function similarly to a fee — the index must exceed the spread before any interest is credited. This is not unusual for volatility-controlled indices, but buyers should model scenarios before relying on those strategies for accumulation.

The Interest Bonus Recovery adds complexity that is easy to underestimate. It is not a fee in the traditional sense, but it is a cost: surrendering early means SILAC can recapture interest it previously credited. That is an unusual provision that most competitors do not include, and it makes the true cost of early exit harder to calculate at the time of purchase.

Legal Entity: SILAC Insurance Company

A.M. Best Rating: B

SILAC Insurance Company is a smaller regional carrier. The B rating from A.M. Best indicates fair financial strength — below the investment-grade threshold that larger annuity carriers typically hold. For a product with a 5-year surrender period, a B rating is worth noting. For a 10-year commitment, it is a primary consideration. SILAC is not unrated or in financial distress, but buyers should factor carrier strength into their analysis alongside product features, particularly given the long surrender duration.